Search

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …

… for this novel technology.” Gerard Platenburg, Chief Innovation Officer at ProQR added, “We are the first to show …

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …

… the unmet medical need in cystic fibrosis and the need for innovative and more efficacious medicines for CF. We look … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …

… Officer of ProQR. “Between Gerard (Platenburg, Chief Innovation Officer), Dave and Noreen we cover all key …

… development. Dr. Friesen has served as Head of Innovation at the Company since June 2016. He obtained a M.S. …

… efficacy endpoints.     “QR-010 has the potential to be an innovative RNA therapy for patients with CF due to the … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …

… central European time in Sevilla, Spain. “QR-010 is an innovative approach to restoring CFTR function in patients … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …